Oral Cefixime Versus Intravenous Piperacillin/Tazobactam and Amikacin in Children With Low-Risk Febrile Neutropenia: An Open-Label Non-Inferiority Randomized Controlled Trial

Authors
Category Primary study
Conference29th Annual Pediatric Hematology Oncology Conference (PHOCON 2026), Chandigarh
Year 2026
This article has no abstract
Epistemonikos ID: b2d7a2eb02efede2f2ac0ee7f0a2fc43bd0700d1
First added on: Oct 17, 2026